Neurontin: 40,000 bottles recalled.
The recall affects about 40,000 bottles of the capsules. The affected lot number is 15224V.
Bottles from this lot were distributed in the United States in October and November of last year.
The drug is indicated for use as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.
For more information, contact Pfizer Inc. by calling 800-438-1985.
|Printer friendly Cite/link Email Feedback|
|Publication:||Internal Medicine News|
|Article Type:||Brief Article|
|Date:||Jul 15, 2005|
|Previous Article:||Pregabalin approved for epilepsy in adults.|
|Next Article:||Pertussis transmission begins at home: how do infants get pertussis? They get it from their family. That's right--their moms and dads, brothers and...|
|Lawsuits fault off-label use of Neurontin in suicide cases.|
|One lot of Neurontin recalled.|